BioPlus Acquisition (BIOS) stock Forecast for 2022 – 2026

BioPlus Acquisition (BIOS) stock Forecast for 2022 – 2026

Last update: January 27, 2023 (07:41)

Sector: Financial

The share price of BioPlus Acquisition Corp. (BIOS) now

What analysts predict: $20
52-week High/Low: $10.31 / $9.78

50/200 Day Moving Average: $10.21 / $10.04

This figure corresponds to the Average Price over the previous 50/200 days. For BioPlus Acquisition stocks, the 50-day moving average is the support level today.

For BioPlus Acquisition stocks, the 200-day moving average is the support level today.

Are you interested in BioPlus Acquisition Corp. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the BioPlus Acquisition stock price in 2023, 2024, 2025, 2026, 2027. How much will one BioPlus Acquisition share be worth in 2023 - 2027?

When should I take profit in BioPlus Acquisition stock? When should I record a loss on BioPlus Acquisition stock? What are analysts' forecasts for BioPlus Acquisition stock? What is the future of BioPlus Acquisition stock? We forecast BioPlus Acquisition stock performance using neural networks based on historical data on BioPlus Acquisition stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

BioPlus Acquisition stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for BioPlus Acquisition shares. This happens once a day.




Historical and forecast chart of BioPlus Acquisition stock

The chart below shows the historical price of BioPlus Acquisition stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the BioPlus Acquisition stock price can be found in the table below.

Long-term forecasts by years.

BioPlus Acquisition daily forecast for a month

Date Target Pes. Opt. Vol., %
Jan 29 10.24 10.02 10.54 5.16
Jan 30 10.21 9.98 10.46 4.78
Jan 31 10.13 9.91 10.30 3.96
Feb 01 10.23 10.03 10.45 4.23
Feb 02 10.27 10.16 10.38 2.15
Feb 03 10.54 10.38 10.80 4.05
Feb 04 10.46 10.23 10.64 4.04
Feb 05 10.50 10.36 10.70 3.27
Feb 06 10.52 10.25 10.63 3.75
Feb 07 10.41 10.10 10.65 5.49
Feb 08 10.48 10.19 10.65 4.54
Feb 09 10.34 10.23 10.46 2.31
Feb 10 10.43 10.14 10.75 5.98
Feb 11 10.39 10.16 10.69 5.17
Feb 12 10.50 10.31 10.59 2.71
Feb 13 10.61 10.39 10.91 5.04
Feb 14 10.81 10.70 11.01 2.96
Feb 15 10.79 10.62 11.10 4.60
Feb 16 10.86 10.67 11.18 4.76
Feb 17 10.78 10.65 11.01 3.31
Feb 18 10.64 10.48 10.79 2.97
Feb 19 10.28 10.09 10.41 3.17
Feb 20 10.34 10.08 10.57 4.79
Feb 21 10.40 10.25 10.51 2.54
Feb 22 10.26 10.03 10.52 4.82
Feb 23 10.63 10.41 10.80 3.72
Feb 24 10.76 10.58 11.03 4.21
Feb 25 10.52 10.39 10.69 2.85
Feb 26 10.68 10.50 10.96 4.37
Feb 27 10.30 10.08 10.44 3.58

BioPlus Acquisition Daily Price Targets


BioPlus Acquisition Stock Forecast 01-29-2023.

Forecast target price for 01-29-2023: $10.24.
Negative dynamics for BioPlus Acquisition shares will prevail with possible volatility of 4.910%.
Pessimistic target level: 10.02
Optimistic target level: 10.54

BioPlus Acquisition Stock Forecast 01-30-2023.

Forecast target price for 01-30-2023: $10.21.
Negative dynamics for BioPlus Acquisition shares will prevail with possible volatility of 4.563%.
Pessimistic target level: 9.98
Optimistic target level: 10.46

BioPlus Acquisition Stock Forecast 01-31-2023.

Forecast target price for 01-31-2023: $10.13.
Negative dynamics for BioPlus Acquisition shares will prevail with possible volatility of 3.813%.
Pessimistic target level: 9.91
Optimistic target level: 10.30

BioPlus Acquisition Stock Forecast 02-01-2023.

Forecast target price for 02-01-2023: $10.23.
Positive dynamics for BioPlus Acquisition shares will prevail with possible volatility of 4.054%.
Pessimistic target level: 10.03
Optimistic target level: 10.45

BioPlus Acquisition Stock Forecast 02-02-2023.

Forecast target price for 02-02-2023: $10.27.
Positive dynamics for BioPlus Acquisition shares will prevail with possible volatility of 2.107%.
Pessimistic target level: 10.16
Optimistic target level: 10.38

BioPlus Acquisition Stock Forecast 02-03-2023.

Forecast target price for 02-03-2023: $10.54.
Positive dynamics for BioPlus Acquisition shares will prevail with possible volatility of 3.892%.
Pessimistic target level: 10.38
Optimistic target level: 10.80

BIOS (BIOS) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Feb. 11.29 10.78 12.00 10.16
Mar. 11.94 11.17 12.44 10.27
Apr. 11.79 11.27 12.14 7.18
May. 10.79 10.28 11.65 11.76
Jun. 10.10 9.44 10.64 11.29
Jul. 10.59 10.29 11.29 8.82
Aug. 10.62 9.97 10.86 8.12
Sep. 10.13 9.83 10.71 8.23
Oct. 10.48 10.15 11.16 9.01
Nov. 9.50 8.74 10.20 14.26
Dec. 8.79 8.24 9.09 9.38

BioPlus Acquisition forecast for this year


BioPlus Acquisition Stock Prediction for Feb 2023

An uptrend is forecast for this month with an optimal target price of $11.2881. Pessimistic: $10.78. Optimistic: $12.00


BioPlus Acquisition Stock Prediction for Mar 2023

An uptrend is forecast for this month with an optimal target price of $11.9428. Pessimistic: $11.17. Optimistic: $12.44


BioPlus Acquisition Stock Prediction for Apr 2023

An downtrend is forecast for this month with an optimal target price of $11.7876. Pessimistic: $11.27. Optimistic: $12.14


BioPlus Acquisition Stock Prediction for May 2023

An downtrend is forecast for this month with an optimal target price of $10.7856. Pessimistic: $10.28. Optimistic: $11.65


BioPlus Acquisition Stock Prediction for Jun 2023

An downtrend is forecast for this month with an optimal target price of $10.0954. Pessimistic: $9.44. Optimistic: $10.64


BioPlus Acquisition Stock Prediction for Jul 2023

An uptrend is forecast for this month with an optimal target price of $10.59. Pessimistic: $10.29. Optimistic: $11.29


BioPlus Acquisition Stock Prediction for Aug 2023

An uptrend is forecast for this month with an optimal target price of $10.6218. Pessimistic: $9.97. Optimistic: $10.86


BioPlus Acquisition Stock Prediction for Sep 2023

An downtrend is forecast for this month with an optimal target price of $10.1332. Pessimistic: $9.83. Optimistic: $10.71


BioPlus Acquisition Stock Prediction for Oct 2023

An uptrend is forecast for this month with an optimal target price of $10.4777. Pessimistic: $10.15. Optimistic: $11.16


BioPlus Acquisition Stock Prediction for Nov 2023

An downtrend is forecast for this month with an optimal target price of $9.5033. Pessimistic: $8.74. Optimistic: $10.20


BioPlus Acquisition Stock Prediction for Dec 2023

An downtrend is forecast for this month with an optimal target price of $8.79055. Pessimistic: $8.24. Optimistic: $9.09



BioPlus Acquisition (BIOS) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 8.55 8.21 9.02 8.92
Feb 9.19 8.68 9.65 10.09
Mar 9.56 9.27 9.93 6.65
Apr 10.47 9.83 11.14 11.75
May 10.24 9.77 10.49 6.84
Jun 10.67 10.12 11.42 11.40
Jul 10.45 9.89 10.81 8.50
Aug 11.49 11.03 11.73 5.97
Sep 11.49 10.71 11.94 10.30
Oct 11.30 10.72 12.01 10.72
Nov 10.88 10.14 11.18 9.34
Dec 10.43 9.62 10.79 10.83

BioPlus Acquisition (BIOS) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 11.29 10.93 11.92 8.33
Feb 11.27 10.53 12.09 12.86
Mar 11.02 10.50 11.31 7.21
Apr 11.13 10.67 11.43 6.62
May 10.14 9.40 10.58 11.21
Jun 10.29 9.48 11.02 14.01
Jul 9.33 8.98 10.04 10.59
Aug 9.18 8.70 9.82 11.41
Sep 9.03 8.65 9.28 6.81
Oct 9.88 9.16 10.22 10.34
Nov 10.48 10.12 10.86 6.76
Dec 11.28 10.56 11.95 11.61

BioPlus Acquisition (BIOS) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 11.92 11.48 12.37 7.23
Feb 12.10 11.38 12.54 9.26
Mar 12.01 11.61 12.39 6.30
Apr 11.48 10.92 12.40 11.94
May 10.46 9.88 11.05 10.51
Jun 10.60 10.28 10.95 6.10
Jul 10.77 10.09 11.51 12.35
Aug 10.66 10.30 11.48 10.31
Sep 10.36 9.55 10.66 10.40
Oct 9.92 9.29 10.57 12.11
Nov 9.48 8.92 10.20 12.55
Dec 10.39 10.00 10.87 7.94

BioPlus Acquisition (BIOS) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 11.19 10.30 11.49 10.32
Feb 11.39 11.01 11.83 6.93
Mar 12.04 11.67 12.98 10.11
Apr 12.98 12.70 13.67 7.03
May 11.87 11.24 12.24 8.15
Jun 11.47 10.68 11.77 9.26
Jul 11.00 10.47 11.24 6.85
Aug 11.31 10.41 12.02 13.36
Sep 11.01 10.74 11.37 5.52
Oct 10.64 10.17 10.99 7.45
Nov 11.11 10.83 11.34 4.51
Dec 10.76 9.98 11.25 11.29

BioPlus Acquisition information and performance

BioPlus Acquisition Corp. operates as a blank check company. It is created for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The company was founded on February 11, 2021 and is headquartered in New York, NY.

BioPlus Acquisition Address

260 MADISON AVENUE, SUITE 800, NEW YORK, NY, US

Market Capitalization: 302 186 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: - $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: None

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: -

Enterprise Value (EV) /Revenue

EV To EBITDA: -

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 23560000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Financial sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.